Groeller and colleagues, the authors highlight that 'globally, an additional 195 million people (a 114% increase) are projected to have type 2 diabetes by 2030 with the prevalence estimated to increase from 2.8% in 2000 to 4.4% by 2030. Existing data suggest that this rise in the incidence of diabetes will be paralleled by a rise in the prevalence of GDM from 2.2% (3 -5% in the US and UK) to 8.8%'. The role of exercise in decreasing this risk and the long-term risk of type 2 diabetes are discussed and the challenge this represents when 50% of non-pregnant women in developed nations already fail to meet the recommended levels of physical activity. The article by Hodson, Robson and Taylor is an excellent review of the emerging science that is improving our understanding of the pathophysiology of pregnancy-related glucose intolerance and the longterm implications of an increased risk of type 2 diabetes and its associated complications in mother and baby.
The article by McLeod and colleagues on subclinical hypothyroidism is yet another example of pregnancy as an opportunity to detect subclinical maternal medical conditions so that diagnosis and intervention occur years earlier. In the USA, the endocrine societies are moving towards a recommendation for universal screening, based on fetal effects, delay in maternal diagnosis and the 30% of cases that are missed with current directed screening recommendations. Collectively these three endocrine articles and the curriculum continue to move us further towards adequate training recommendations and an understanding of how pregnancy as a stress test provides a window of opportunity for prevention and early detection. 
